As well as an Adjunct Assistant Professer for GWU, Daryl Pritchard, Ph.D., is the Senior Vice President of Science Policy at the Personalized Medicine Coalition (PMC), where he leads PMC’s efforts to increase awareness and understanding of personalized medicine; identify and address barriers to the adoption of personalized medicine into the health care system; and develop and promote appropriate clinical, health care infrastructure, regulatory, and payment policies that will help advance patient-centered, personalized health care.
Before coming to PMC, Dr. Pritchard served as the Director of Policy Research at the National Pharmaceutical Council (NPC). Prior to joining NPC, he served as the Director of Research Programs Advocacy and Personalized Medicine at the Biotechnology Industry Organization (BIO).
Dr. Pritchard received his Ph.D. and master’s degree in Genetics from the George Washington University, and completed a post-doctoral research fellowship at the Children’s National Medical Center. He was awarded the first American Society of Human Genetics (ASHG)/National Human Genome Research Institute (NHGRI) Fellowship in Genetics and Public Policy, where he worked as a health legislative assistant in the House of Representatives.
Research
Dr. Pritchard's research interests span the fields of Genetics and Personalized Medicine, including oncology, pharmacogenetics, rare and undiagnosed disease, health care policy, health economics and outcomes research, and health technology implementation.
Teaching
- PHAR 6116
Centers and Institutes
- Personalized Medicine Coalition, Washington DC.
- George Washington University, Columian College of Arts and Science, Department of Pharmacology, Washington DC.